Radient

Radient

Radient

Radient Technologies Inc. Receives License Amendment from Health Canada for its Edmonton II Facility and Closes First Tranche of its Previously Announced Debenture Financing

Radient Technologies Inc. Receives License Amendment from Health Canada for its Edmonton II Facility and Closes First Tranche of its Previously Announced Debenture Financing

Radient Technologies Inc. Reports Record Revenue and Record Gross Profit for the Third Quarter of Fiscal 2020

Radient Technologies Inc. Signs Supply Agreement with Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart Inc., for the Formulation and Manufacturing of Exclusive Branded Cannabis Products

Radient Technologies Inc. Announces up to CAD $15.4 Million in Debenture Financings and Provides Corporate Update

Radient Technologies Inc. Announces Changes to its Board of Directors

Radient Technologies Inc. Signs Binding Letter of Intent to Enter into Sale-Leaseback Financing Agreement and Reaffirms Revenue Guidance of at Least $10 Million for Fiscal Q3 2020

This website is best viewed using the latest versions of web browsers.